C. van der Ent

Anti-TNF Levels in Cord Blood at Birth are Associated with Anti-TNF Type

D. Rizopoulos, C. J. van der Woude, S. Kanis, 2018, Journal of Crohn's & colitis.

Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure.

E. Kuipers, C. J. van der Woude, Z. Zelinková, 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Analysing the protection from respiratory tract infections and allergic diseases early in life by human milk components: the PRIMA birth cohort

M. Benders, E. Sanders, A. Kraneveld, 2022, BMC Infectious Diseases.

Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety

C. J. van der Woude, E. Steegers, C. van der Ent, 2015, Gut.

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients

M. Peppelenbosch, C. J. van der Woude, G. Fuhler, 2018, Journal of Translational Medicine.

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients

M. Peppelenbosch, G. Fuhler, C. J. van der Woude, 2018, Journal of Translational Medicine.